Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (1) | Back to Search
Advanced therapy medicinal product in Europe
- In: C7 - Advanced therapies: pharmaceuticals’ new dimension? on Wednesday, 1 September 2010, 9:00-12:00
- At: Lisbon (Portugal) (2010)
- Type: Presentation
- By: CELIS, Patrick (European Medicines Agency, London, United Kingdom)
- Abstract:
In Europe, Advanced therapy medicinal products (ATMPs) are defined as the following medicinal products for human use: gene therapy medicinal products (GTMP), somatic cell therapy products (CTMP) and tissue engineered products (TEP). Whereas GTMP and CTMP where already clearly defined as medicinal product in Europe since 2003, it is only since the
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023